{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:04:48Z","timestamp":1763744688350},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,11,10]],"date-time":"2011-11-10T00:00:00Z","timestamp":1320883200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1038\/hr.2011.184","type":"journal-article","created":{"date-parts":[[2011,11,10]],"date-time":"2011-11-10T07:07:19Z","timestamp":1320908839000},"page":"348-355","source":"Crossref","is-referenced-by-count":14,"title":["Azelnidipine attenuates glomerular damage in Dahl salt-sensitive rats by suppressing sympathetic nerve activity"],"prefix":"10.1038","volume":"35","author":[{"given":"Hajime","family":"Nagasu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohachi","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naruya","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamaki","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Kashihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,10]]},"reference":[{"key":"BFhr2011184_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1053\/ajkd.2000.16225","volume":"36","author":"GL Bakris","year":"2000","unstructured":"Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J . Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000; 36: 646\u2013661.","journal-title":"Am J Kidney Dis"},{"key":"BFhr2011184_CR2","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/ki.1993.114","volume":"43","author":"LD Dworkin","year":"1993","unstructured":"Dworkin LD, Benstein JA, Parker M, Tolbert E, Feiner HD . Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms. Kidney Int 1993; 43: 808\u2013814.","journal-title":"Kidney Int"},{"key":"BFhr2011184_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1161\/01.HYP.20.2.233","volume":"20","author":"UO Wenzel","year":"1992","unstructured":"Wenzel UO, Troschau G, Schoeppe W, Helmchen U, Schwietzer G . Adverse effect of the calcium channel blocker nitrendipine on nephrosclerosis in rats with renovascular hypertension. Hypertension 1992; 20: 233\u2013241.","journal-title":"Hypertension"},{"key":"BFhr2011184_CR4","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/j.1523-1755.2004.00859.x","volume":"66","author":"G Ma","year":"2004","unstructured":"Ma G, Allen TJ, Cooper ME, Cao Z . Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetes. Kidney Int 2004; 66: 1090\u20131098.","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"BFhr2011184_CR5","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1097\/01.ASN.0000093242.48333.3B","volume":"15","author":"A Salvetti","year":"2004","unstructured":"Salvetti A, Ghiadoni L . Guidelines for antihypertensive treatment: an update after the ALLHAT study. J Am Soc Nephrol 2004; 15 (Suppl 1): S51\u2013S54.","journal-title":"J Am Soc Nephrol"},{"key":"BFhr2011184_CR6","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0140-6736(00)02527-7","volume":"356","author":"MJ Brown","year":"2000","unstructured":"Brown MJ, Palmer CR, Castaigne A, de Leeuw PW, Mancia G, Rosenthal T, Ruilope LM . Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000; 356: 366\u2013372.","journal-title":"Lancet"},{"key":"BFhr2011184_CR7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1161\/01.RES.0000256155.31133.49","volume":"100","author":"K Hayashi","year":"2007","unstructured":"Hayashi K, Wakino S, Sugano N, Ozawa Y, Homma K, Saruta T . Ca2+ channel subtypes and pharmacology in the kidney. Circ Res 2007; 100: 342\u2013353.","journal-title":"Circ Res"},{"key":"BFhr2011184_CR8","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1001\/archinte.1994.00420110021004","volume":"154","author":"PM ter Wee","year":"1994","unstructured":"ter Wee PM, De Micheli AG, Epstein M . Effects of calcium antagonists on renal hemodynamics and progression of nondiabetic chronic renal disease. Arch Intern Med 1994; 154: 1185\u20131202.","journal-title":"Arch Intern Med"},{"key":"BFhr2011184_CR9","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1097\/01.hjh.0000244956.47114.c1","volume":"24","author":"E Yamamoto","year":"2006","unstructured":"Yamamoto E, Lai ZF, Yamashita T, Tanaka T, Kataoka K, Tokutomi Y, Ito T, Ogawa H, Kim-Mitsuyama S . Enhancement of cardiac oxidative stress by tachycardia and its critical role in cardiac hypertrophy and fibrosis. J Hypertens 2006; 24: 2057\u20132069.","journal-title":"J Hypertens"},{"key":"BFhr2011184_CR10","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/FJC.0b013e318192690e","volume":"52","author":"S Konno","year":"2008","unstructured":"Konno S, Hirooka Y, Araki S, Koga Y, Kishi T, Sunagawa K . Azelnidipine decreases sympathetic nerve activity via antioxidant effect in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol 2008; 52: 555\u2013560.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFhr2011184_CR11","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1093\/ndt\/gfp407","volume":"24","author":"S Fujimoto","year":"2009","unstructured":"Fujimoto S, Satoh M, Nagasu H, Horike H, Sasaki T, Kashihara N . Azelnidipine exerts renoprotective effects by improvement of renal microcirculation in angiotensin II infusion rats. Nephrol Dial Transplant 2009; 24: 3651\u20133658.","journal-title":"Nephrol Dial Transplant"},{"key":"BFhr2011184_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/MAJ.0b013e318065c254","volume":"333","author":"T Nakamura","year":"2007","unstructured":"Nakamura T, Sugaya T, Kawagoe Y, Suzuki T, Ueda Y, Koide H, Inoue T, Node K . Azelnidipine reduces urinary protein excretion and urinary liver-type fatty acid binding protein in patients with hypertensive chronic kidney disease. Am J Med Sci 2007; 333: 321\u2013326.","journal-title":"Am J Med Sci"},{"key":"BFhr2011184_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s11906-002-0012-7","volume":"4","author":"M Tuncel","year":"2002","unstructured":"Tuncel M, Augustyniak R, Zhang W, Toto RD, Victor RG . Sympathetic nervous system function in renal hypertension. Curr Hypertens Rep 2002; 4: 229\u2013236.","journal-title":"Curr Hypertens Rep"},{"key":"BFhr2011184_CR14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1681\/ASN.V13127","volume":"13","author":"KM Denton","year":"2002","unstructured":"Denton KM, Shweta A, Anderson WP . Preglomerular and postglomerular resistance responses to different levels of sympathetic activation by hypoxia. J Am Soc Nephrol 2002; 13: 27\u201334.","journal-title":"J Am Soc Nephrol"},{"key":"BFhr2011184_CR15","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1291\/hypres.28.1017","volume":"28","author":"T Shokoji","year":"2005","unstructured":"Shokoji T, Fujisawa Y, Kiyomoto H, Rahman M, Sun GP, Fan YY, Kimura S, Kohno M, Abe Y, Nishiyama A . Effects of a new calcium channel blocker, azelnidipine, on systemic hemodynamics and renal sympathetic nerve activity in spontaneously hypertensive rats. Hypertens Res 2005; 28: 1017\u20131023.","journal-title":"Hypertens Res"},{"key":"BFhr2011184_CR16","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/FJC.0b013e31804d1cf1","volume":"49","author":"K Eguchi","year":"2007","unstructured":"Eguchi K, Tomizawa H, Ishikawa J, Hoshide S, Fukuda T, Numao T, Shimada K, Kario K . Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure. J Cardiovasc Pharmacol 2007; 49: 394\u2013400.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFhr2011184_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1161\/01.RES.59.2.178","volume":"59","author":"M Pagani","year":"1986","unstructured":"Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, Sandrone G, Malfatto G, Dell\u2019Orto S, Piccaluga E, Turiel M, Baselli G, Cerutti S, Malliani A . Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 1986; 59: 178\u2013193.","journal-title":"Circ Res"},{"key":"BFhr2011184_CR18","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1161\/01.CIR.84.2.482","volume":"84","author":"A Malliani","year":"1991","unstructured":"Malliani A, Pagani M, Lombardi F, Cerutti S . Cardiovascular neural regulation explored in the frequency domain. Circulation 1991; 84: 482\u2013492.","journal-title":"Circulation"},{"key":"BFhr2011184_CR19","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/oxfordjournals.eurheartj.a014868","volume":"17","author":"Heart rate variability","year":"1996","unstructured":"Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 1996; 17: 354\u2013381.","journal-title":"Eur Heart J"},{"key":"BFhr2011184_CR20","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1093\/ndt\/gfq139","volume":"25","author":"H Nagasu","year":"2010","unstructured":"Nagasu H, Satoh M, Kuwabara A, Yorimitsu D, Sakuta T, Tomita N, Kashihara N . Renal denervation reduces glomerular injury by suppressing NAD(P)H oxidase activity in Dahl salt-sensitive rats. Nephrol Dial Transplant 2010; 25: 2889\u20132898.","journal-title":"Nephrol Dial Transplant"},{"key":"BFhr2011184_CR21","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1291\/hypres.31.745","volume":"31","author":"T Namikoshi","year":"2008","unstructured":"Namikoshi T, Tomita N, Satoh M, Haruna Y, Kobayashi S, Komai N, Sasaki T, Kashihara N . Pioglitazone enhances the antihypertensive and renoprotective effects of candesartan in Zucker obese rats fed a high-protein diet. Hypertens Res 2008; 31: 745\u2013755.","journal-title":"Hypertens Res"},{"key":"BFhr2011184_CR22","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1046\/j.1523-1755.2001.0590041342.x","volume":"59","author":"AS Reddi","year":"2001","unstructured":"Reddi AS, Bollineni JS . Selenium-deficient diet induces renal oxidative stress and injury via TGF-beta1 in normal and diabetic rats. Kidney Int 2001; 59: 1342\u20131353.","journal-title":"Kidney Int"},{"key":"BFhr2011184_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1291\/hypres.31.305","volume":"31","author":"S Fujimoto","year":"2008","unstructured":"Fujimoto S, Satoh M, Horike H, Hatta H, Haruna Y, Kobayashi S, Namikoshi T, Arakawa S, Tomita N, Kashihara N . Olmesartan ameliorates progressive glomerular injury in subtotal nephrectomized rats through suppression of superoxide production. Hypertens Res 2008; 31: 305\u2013313.","journal-title":"Hypertens Res"},{"key":"BFhr2011184_CR24","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1097\/00004872-200111000-00014","volume":"19","author":"M Honda","year":"2001","unstructured":"Honda M, Hayashi K, Matsuda H, Kubota E, Tokuyama H, Okubo K, Takamatsu I, Ozawa Y, Saruta T . Divergent renal vasodilator action of L- and T-type calcium antagonists in vivo. J Hypertens 2001; 19: 2031\u20132037.","journal-title":"J Hypertens"},{"key":"BFhr2011184_CR25","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1291\/hypres.30.621","volume":"30","author":"T Ishimitsu","year":"2007","unstructured":"Ishimitsu T, Kameda T, Akashiba A, Takahashi T, Ohta S, Yoshii M, Minami J, Ono H, Numabe A, Matsuoka H . Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis. Hypertens Res 2007; 30: 621\u2013626.","journal-title":"Hypertens Res"},{"key":"BFhr2011184_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1161\/01.RES.71.2.471","volume":"71","author":"T Takenaka","year":"1992","unstructured":"Takenaka T, Forster H, De Micheli A, Epstein M . Impaired myogenic responsiveness of renal microvessels in Dahl salt-sensitive rats. Circ Res 1992; 71: 471\u2013480.","journal-title":"Circ Res"},{"key":"BFhr2011184_CR27","doi-asserted-by":"publisher","first-page":"H1881","DOI":"10.1152\/ajpheart.2001.281.5.H1881","volume":"281","author":"BS Huang","year":"2001","unstructured":"Huang BS, Wang H, Leenen FH . Enhanced sympathoexcitatory and pressor responses to central Na+ in Dahl salt-sensitive vs. -resistant rats. Am J Physiol Heart Circ Physiol 2001; 281: H1881\u2013H1889.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFhr2011184_CR28","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/0002-9149(91)90243-E","volume":"68","author":"ED Frohlich","year":"1991","unstructured":"Frohlich ED, McLoughlin MJ, Losem CJ, Ketelhut R, Messerli FH . Hemodynamic comparison of two nifedipine formulations in patients with essential hypertension. Am J Cardiol 1991; 68: 1346\u20131350.","journal-title":"Am J Cardiol"},{"key":"BFhr2011184_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.brainres.2007.07.038","volume":"1176","author":"V Lukic-Panin","year":"2007","unstructured":"Lukic-Panin V, Kamiya T, Zhang H, Hayashi T, Tsuchiya A, Sehara Y, Deguchi K, Yamashita T, Abe K . Prevention of neuronal damage by calcium channel blockers with antioxidative effects after transient focal ischemia in rats. Brain Res 2007; 1176: 143\u2013150.","journal-title":"Brain Res"},{"key":"BFhr2011184_CR30","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1097\/00005344-200405000-00016","volume":"43","author":"S Yamagishi","year":"2004","unstructured":"Yamagishi S, Inagaki Y, Nakamura K, Imaizumi T . Azelnidipine, a newly developed long-acting calcium antagonist, inhibits tumor necrosis factor-alpha-induced interleukin-8 expression in endothelial cells through its anti-oxidative properties. J Cardiovasc Pharmacol 2004; 43: 724\u2013730.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFhr2011184_CR31","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1161\/01.HYP.0000179088.57586.26","volume":"46","author":"VM Campese","year":"2005","unstructured":"Campese VM, Shaohua Y, Huiquin Z . Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 2005; 46: 533\u2013539.","journal-title":"Hypertension"},{"key":"BFhr2011184_CR32","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1161\/HYPERTENSIONAHA.107.091009","volume":"50","author":"M Fujita","year":"2007","unstructured":"Fujita M, Ando K, Nagae A, Fujita T . Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in salt-sensitive hypertension. Hypertension 2007; 50: 360\u2013367.","journal-title":"Hypertension"},{"key":"BFhr2011184_CR33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1291\/hypres.29.49","volume":"29","author":"Y Hirooka","year":"2006","unstructured":"Hirooka Y, Kimura Y, Nozoe M, Sagara Y, Ito K, Sunagawa K . Amlodipine-induced reduction of oxidative stress in the brain is associated with sympatho-inhibitory effects in stroke-prone spontaneously hypertensive rats. Hypertens Res 2006; 29: 49\u201356.","journal-title":"Hypertens Res"},{"key":"BFhr2011184_CR34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/HJH.0b013e3280104dba","volume":"25","author":"M Lindqvist","year":"2007","unstructured":"Lindqvist M, Kahan T, Melcher A, Ekholm M, Hjemdahl P . Long-term calcium antagonist treatment of human hypertension with mibefradil or amlodipine increases sympathetic nerve activity. J Hypertens 2007; 25: 169\u2013175.","journal-title":"J Hypertens"},{"key":"BFhr2011184_CR35","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1038\/sj.ki.5001835","volume":"70","author":"GL Bakris","year":"2006","unstructured":"Bakris GL, Hart P, Ritz E . Beta blockers in the management of chronic kidney disease. Kidney Int 2006; 70: 1905\u20131913.","journal-title":"Kidney Int"},{"key":"BFhr2011184_CR36","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(98)07614-4","volume":"353","author":"JE Dickerson","year":"1999","unstructured":"Dickerson JE, Hingorani AD, Ashby MJ, Palmer CR, Brown MJ . Optimisation of antihypertensive treatment by crossover rotation of four major classes. Lancet 1999; 353: 2008\u20132013.","journal-title":"Lancet"},{"key":"BFhr2011184_CR37","first-page":"1121","volume":"336","author":"F Turnbull","year":"2008","unstructured":"Turnbull F, Neal B, Ninomiya T, Algert C, Arima H, Barzi F, Bulpitt C, Chalmers J, Fagard R, Gleason A, Heritier S, Li N, Perkovic V, Woodward M, MacMahon S . Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 2008; 336: 1121\u20131123.","journal-title":"BMJ"},{"key":"BFhr2011184_CR38","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","volume":"359","author":"K Jamerson","year":"2008","unstructured":"Jamerson K, Weber MA, Bakris GL, Dahlof B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ . Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359: 2417\u20132428.","journal-title":"N Engl J Med"},{"key":"BFhr2011184_CR39","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/10641960902822492","volume":"31","author":"T Kishi","year":"2009","unstructured":"Kishi T, Hirooka Y, Konno S, Sunagawa K . Cilnidipine inhibits the sympathetic nerve activity and improves baroreflex sensitivity in patients with hypertension. Clin Exp Hypertens 2009; 31: 241\u2013249.","journal-title":"Clin Exp Hypertens"},{"key":"BFhr2011184_CR40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1253\/circj.67.139","volume":"67","author":"K Harada","year":"2003","unstructured":"Harada K, Nomura M, Nishikado A, Uehara K, Nakaya Y, Ito S . Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities. Circ J 2003; 67: 139\u2013145.","journal-title":"Circ J"},{"key":"BFhr2011184_CR41","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1111\/j.1523-1755.2004.00552.x","volume":"65","author":"J Neumann","year":"2004","unstructured":"Neumann J, Ligtenberg G, Klein II, Koomans HA, Blankestijn PJ . Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment. Kidney Int 2004; 65: 1568\u20131576.","journal-title":"Kidney Int"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr2011184.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2011184","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2011184.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:08:45Z","timestamp":1684429725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr2011184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,10]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["BFhr2011184"],"URL":"https:\/\/doi.org\/10.1038\/hr.2011.184","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,10]]}}}